| European Case Law Identifier: | ECLI:EP:BA:2016:T136712.20160122 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 22 January 2016 | ||||||||
| Case number: | T 1367/12 | ||||||||
| Application number: | 02017012.2 | ||||||||
| IPC class: | G06F 19/00 A61B 5/00 A61M 5/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Diabetes management system | ||||||||
| Applicant name: | Roche Diagnostics GmbH F. Hoffmann-La Roche AG |
||||||||
| Opponent name: | Medtronic MiniMed, Inc. | ||||||||
| Board: | 3.5.05 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Grounds for opposition - insufficiency of disclosure (no) Remittal to the department of first instance - (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t121367eu1.html
Date retrieved: 17 May 2021